References
- KL Goa, and RC Heel. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as a hypnotic. Drugs 1986; 3248–65.
- S Nobel, HD Langtry, and HM Lamb. Zopiclone: an update of its pharmacology, clinical efficacy, and tolerability in the treatment of insomnia. Drugs 1998; 55277–302.
- AN Wadworth, and D McTavish. Zopiclone: a review of its pharmacological properties and therapeutic efficacy as a hypnotic. Drugs Aging 1993; 3441–459.
- PJ Kulka, and PM Lauven. Benzodiazepine antagonists: an update of their role in the emergency care of overdose patients. Drug Saf 1992; 7381–386.
- DL Seger. Flumazenil – treatment or toxin. Clin Toxicol 2004; 42209–216.
- ASY Ngo, CR Anthony, M Samuel, E Wong, and R Ponampalam. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department?. Resuscitation 2007; 4:27–37.
- RR Trifiletti, and SH Snyder. Anxiolytic cyclopyrrolones zopiclone and sucrilone bind to a novel site linked allosterically to benzodiazepine receptors. Mol Pharmacol 1984; 26458–469.
- Z Ahmad, M Herepath, and P Ebden. Diagnostic utility of flumazenil in coma with suspected poisoning. Br Med J 1991; 302:292.
- JJ Cienki, KK Burkhart, and JW Donovan. Zopiclone overdose responsive to flumazenil. Clin Toxicol 2005; 43385–386.